Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severin Daum

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|March 24, 2022
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative ChemotherapyAlexej Ballhausen, Prisca Bartels, Ines Iacovella, et al.
Plos One|December 29, 2016
Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal AdenocarcinomasChristoph Treese, Pedro Sanchez, Patricia Grabowski, et al.
International Journal of Colorectal Disease|October 4, 2016
Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndromeChristian Barmeyer, Michael Schumann, Tim Meyer, et al.
Oncology|April 1, 2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal AdenocarcinomaDmitry Bichev, Christoph Treese, Moritz von Winterfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's LymphomaSeverin Daum, Reiner Ullrich, Walter Heise, et al.
Anticancer Research|August 8, 2009
Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at CharitéSebastian Ochsenreither, Simone Marnitz-Schultze, Achim Schneider, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2022
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsiesKarsten Kleo, Vladimir M Jovanovic, Alexander Arndold, et al.
Annals of the New York Academy of Sciences|June 27, 2012
Defective tight junctions in refractory celiac diseaseMichael Schumann, Sarah Kamel, Marie-Luise Pahlitzsch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 14, 2026
Prognostic impact of TROP2 in adenocarcinoma of the esophageal junction and stomachAnselm Pittrof, Alexander Arnold, Severin Daum, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2023
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumorsVivien Topf, Yuri Kheifetz, Severin Daum, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|March 24, 2022
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative ChemotherapyAlexej Ballhausen, Prisca Bartels, Ines Iacovella, et al.
Plos One|December 29, 2016
Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal AdenocarcinomasChristoph Treese, Pedro Sanchez, Patricia Grabowski, et al.
International Journal of Colorectal Disease|October 4, 2016
Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndromeChristian Barmeyer, Michael Schumann, Tim Meyer, et al.
Oncology|April 1, 2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal AdenocarcinomaDmitry Bichev, Christoph Treese, Moritz von Winterfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's LymphomaSeverin Daum, Reiner Ullrich, Walter Heise, et al.
Anticancer Research|August 8, 2009
Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at CharitéSebastian Ochsenreither, Simone Marnitz-Schultze, Achim Schneider, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2022
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsiesKarsten Kleo, Vladimir M Jovanovic, Alexander Arndold, et al.
Annals of the New York Academy of Sciences|June 27, 2012
Defective tight junctions in refractory celiac diseaseMichael Schumann, Sarah Kamel, Marie-Luise Pahlitzsch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 14, 2026
Prognostic impact of TROP2 in adenocarcinoma of the esophageal junction and stomachAnselm Pittrof, Alexander Arnold, Severin Daum, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2023
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumorsVivien Topf, Yuri Kheifetz, Severin Daum, et al.
Pageof 6